Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells
about
Diverse mechanisms of antiepileptic drugs in the development pipelinePotent KCNQ2/3-specific channel activator suppresses in vivo epileptic activity and prevents the development of tinnitusHomomeric and heteromeric assembly of KCNQ (Kv7) K+ channels assayed by total internal reflection fluorescence/fluorescence resonance energy transfer and patch clamp analysis.Multiple-dose, linear, dose-proportional pharmacokinetics of retigabine in healthy volunteers.Activation of voltage-gated KCNQ/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats.Retigabine/Ezogabine, a KCNQ/K(V)7 channel opener: pharmacological and clinical data.Molecular expression and pharmacological evidence for a functional role of kv7 channel subtypes in Guinea pig urinary bladder smooth muscleMajor diversification of voltage-gated K+ channels occurred in ancestral parahoxozoans.Activation of vascular KCNQ (Kv7) potassium channels reverses spasmogen-induced constrictor responses in rat basilar artery.KV7 channels regulate muscle tone and nonadrenergic noncholinergic relaxation of the rat gastric fundus.Contributions of Kv7-mediated potassium current to sub- and suprathreshold responses of rat layer II/III neocortical pyramidal neurons.Characteristics and molecular basis of celecoxib modulation on K(v)7 potassium channels.Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy.Atomic basis for therapeutic activation of neuronal potassium channels.Hippocalcin and KCNQ channels contribute to the kinetics of the slow afterhyperpolarization.Dynamic subunit stoichiometry confers a progressive continuum of pharmacological sensitivity by KCNQ potassium channels.Mechanism of Cancer Growth Suppression of Alpha-Fetoprotein Derived Growth Inhibitory Peptides (GIP): Comparison of GIP-34 versus GIP-8 (AFPep). Updates and ProspectsDifferential protein kinase C-dependent modulation of Kv7.4 and Kv7.5 subunits of vascular Kv7 channels.The contribution of Kv7 channels to pregnant mouse and human myometrial contractility.Retigabine (ezogabine): in partial-onset seizures in adults with epilepsy.Novel medications for epilepsy.The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy.Distribution of M-channel subunits KCNQ2 and KCNQ3 in rat hippocampusKCNQ modulators reveal a key role for KCNQ potassium channels in regulating the tone of rat pulmonary artery smooth muscle.Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currentsMolecular correlates of the M-current in cultured rat hippocampal neurons.Pharmacokinetic interaction between retigabine and lamotrigine in healthy subjects.Voltage-independent KCNQ4 currents induced by (+/-)BMS-204352.The role of Gilbert's syndrome and frequent NAT2 slow acetylation polymorphisms in the pharmacokinetics of retigabine.Ionic mechanisms of autorhythmic firing in rat cerebellar Golgi cells.Do KV 7.1 channels contribute to control of arterial vascular tone?Activation of KCNQ Channels Suppresses Spontaneous Activity in Dorsal Root Ganglion Neurons and Reduces Chronic Pain after Spinal Cord Injury.
P2860
Q24675330-ED7049B3-78FB-4B68-B254-1066B8BF5041Q30396439-24B3C370-5EBF-4861-9347-830D4DB9EFF0Q30485406-0CDF1463-12D2-452C-8D84-BE05CF3AB342Q33845614-AED82C4F-735C-43DB-9B01-F3D3A7A67A31Q34114419-C008ECB7-68D2-46C4-A7DD-7B12B36AE8F3Q34333196-0AFC77E4-35B6-45D4-A6CA-E5EA41E4D22BQ35000941-5029C12A-7088-4BF4-B6C9-192DA64A6B95Q35157106-959E76C1-2FCE-4EC8-AB44-E579CBF5B014Q35216454-B01F49CF-9AAC-4724-A64D-9785DA7D8D0CQ35228397-7C002972-D26D-4B2A-B14C-6BA682B32ED2Q35326586-9BAEEE67-F57A-48C0-AABB-6C3A49ED4062Q35593089-2F69F7A7-037A-494D-A80F-ECA8D06C1A2BQ35950205-83B1CEFF-3A74-48FF-8415-5802F8CCF47DQ36033788-57DE0483-06C5-4487-89E9-5B498C9351FEQ36476692-D4B0F484-122C-49F1-A093-98FA39BB0678Q36884182-79E011EB-DC9A-4B67-B529-AEC53ED9C4A8Q37132813-C3253E08-3B34-4209-BDDB-691DE289F0C9Q37511713-98D0F914-2B0E-4638-B1C5-F2702269A060Q37580235-DA3F8514-DE9F-45A6-9821-EE7E7524D629Q37936428-84F2B4BD-1333-452F-AF59-983FE0A755ACQ37950518-E079FF48-1377-46E9-8C3D-0832E8C57DA4Q37973378-7DA962A7-D30A-4B05-A8B9-3EB47B4E13F0Q38295716-E5C849C0-EC1C-44D8-80A9-9F06EE006776Q42110971-B275C920-8BCB-4B9C-BA86-55AF35C6FFA2Q42424886-2DF2C3F3-3BAB-42C2-86F5-AA298CDC5064Q44161111-2615CCA3-25D0-47F8-9D73-623E65FC07D3Q44405609-A430B501-8D0A-45FB-9B12-DC3593E2E950Q44507292-5A3B1152-3029-46B0-8095-DADFE4DB3366Q46886423-23D33C37-FF16-4F5E-B55B-88A4A8F4D336Q47852103-4BE54E35-63F4-4972-A95C-3DF62FD2A5F0Q49924020-8D47BD49-3A85-4F68-AB07-00C753D9B339Q50959625-3A7FC30A-A033-45E6-84A3-AB131D2E5C24
P2860
Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells
@ast
Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells
@en
Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells
@nl
type
label
Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells
@ast
Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells
@en
Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells
@nl
prefLabel
Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells
@ast
Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells
@en
Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells
@nl
P2093
P2860
P356
P1476
Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells
@en
P2093
P2860
P356
10.1038/SJ.BJP.0703861
P407
P577
2001-01-01T00:00:00Z